EvoSkin

Genoskin is a biotechnology company specializing in the development and commercialization of standardized, live human skin models for ex vivo testing. Originally founded as EvoSkin, the company provides a unique alternative to animal testing by maintaining the functional structure and viability of human skin biopsies. Its core platforms, including NativeSkin, HypoSkin, and InflammaSkin, allow pharmaceutical and cosmetic researchers to study drug penetration, metabolism, and efficacy in a highly predictive human environment. Genoskin's technology is widely utilized by global leaders in the pharmaceutical and dermo-cosmetic industries to de-risk clinical development and accelerate the transition from lab to clinic.